Compare Fox Corp Class B (FOX) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs Neurocrine Biosciences Inc — how do they compare? Fox Corp Class B trades at $51.12 (market cap $22.28B), while Neurocrine Biosciences Inc trades at $171.87 (market cap $17.30B). The key difference: Fox Corp Class B is the larger of the two by market cap, and Fox Corp Class B pays a 1.11% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| FOX | NBIX | |
|---|---|---|
Market Cap | $22.28B | $17.30B |
Sector | Media | Health |
52-Week High | $67.76 | $180.55 |
52-Week Low | $44.39 | $123.10 |
Enterprise Value | $26.25B | $16.39B |
Dividend Yield | 1.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOX trades at $49.50, down 1.43% today, with technical indicators showing a neutral to bearish short-term bias. The company demonstrates strong fundamental performance with Q1 2026 EPS beating expectations at $1.32 versus $0.988, continuing a trend of earnings surprises. Revenue grew to $16.3B in 2025 with net income margin expanding to 13.88%. Analyst sentiment is mixed with 43% buy ratings but technical weakness persists near key support levels.
The outlook remains cautiously optimistic given FOX's consistent earnings beats and improved cash flow generation, though technical weakness and competitive pressures in media streaming present near-term challenges. The stock offers reasonable valuation with P/E of 13.26x, but investors should monitor advertising trends and Roku integration execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
